See more here:
ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at EMUC 2024

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh